Please login to the form below

Not currently logged in
Email:
Password:

New member for Baxterís board of directors

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007.

Hockmeyer founded MedImmune and served as its CEO and chairman from 1988 to 2000. MedImmune develops therapies for infectious disease, inflammatory disease and cancer and was recently acquired by AstraZeneca.

"Wayne is an exciting addition to our board of directors and we welcome the strong executive, scientific and operational experience he brings," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "His extensive scientific and R&D expertise will be invaluable in helping Baxter achieve its innovation and growth objectives."

Before Medimmune, Hockmeyer was vice-president of laboratory research and product development at Praxis Biologics and served as chief of the department of immunology at Walter Reed Army Institute of Research.

Hockmeyer is a member of the boards of directors of Middlebrook Pharmaceuticals, GenVec and Idenix Pharmaceuticals.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics